Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7317 p380-382
18 September 2004

This article
Reprint   Photocopy

PDF 110K, Acrobat Reader

Letters

· Counterfeit drugs
· Packaging
· Simvastatin
· Shipman inquiry
· The register
· Personal control
· The Society
· New contract
· Employee pharmacists
· Tuberculosis
· Retention fee
· Overseas membership
· Onlooker


Letters to the Editor

Personal control

Pedantry of outdated legislation

If it ain’t broke ...

Rectify this ridiculous position!

Legal position should be changed

Crass legislation

Non-registered areas

A few simple rules

Absurd anomaly

Pedantry of outdated legislation

From Mr C. Morris, MRPharmS

Yet again I am staggered at the pure inanity of legislation regarding pharmacy supervision. The letters in The Journal of 11 September saying that surely the counter assistants’ training must count for something when it comes to selling GSL medicines without the presence of a pharmacist must be all correct. This is just common sense. After all, how much training does the work experience lad get in your local convenience store.

The answer from Lynsey Balmer (ibid, p345) highlights the pedantry of the outdated legislation: when I work at a local supermarket pharmacy and I go for lunch we cannot sell 16 aspirin from aisle 4 (a registered pharmacy) but the ones in aisle 5 are fine. Come on! How about doing the profession some good for the 25 per cent increase in payments that is now required.

Not only is our profession the lowest paid, it must appear to the public to be the most pedantic.

Chris Morris
Newquay, Cornwall


If it ain’t broke ...

From Mr H. Littler, MRPharmS

Recent letters on personal control have done nothing to clarify the matter; indeed, quite the reverse.

Briefly, and without going into technicalities, the position is that a person (which term includes a corporate body) lawfully conducting a retail pharmacy business may sell or supply in circumstances corresponding to retail sale medicinal products not on a General Sale List (pharmacy medicines and most dispensed medicines) from registered premises subject to certain conditions.

One of those conditions is that the business, so far as concerns the retail sale of medicinal products (whether they are on a General Sale List or not), or the supply of such products in circumstances corresponding to retail sale, is under the personal control of a registered pharmacist.

It follows from this that if the condition of personal control is not observed sales of pharmacy medicines or supplies of dispensed medicines from the premises would be unlawful and any prosecution resulting from an allegation that the business was being carried on other than under the personal control of a registered pharmacist would be based on those unlawful sales.

Sales of GSL medicines during short absences of a pharmacist are not a problem. It is the business which must be under the personal control of a pharmacist and not individual sales of GSL medicines. Just how long the pharmacist could be absent without breaching the condition regarding personal control is a matter for the courts.

To those who advocate removal of the personal control condition I would put the following question. Would you be content for a registered pharmacy business to be carried on in circumstances where:

· The title “pharmacy” was prominently displayed at the premises?

· There was no pharmacist in full-time control?

· The staff were encouraged to sell GSL medicines in the absence of a pharmacist?

· The staff were instructed to contact a pharmacist working at nearby premises, possibly a busy pharmacy, in the event of a request for the supply of a pharmacy medicine of for a prescription to be dispensed when, in response to such a request, the pharmacist attended only long enough to supervise the supply or supplies prescription turnover was low?

Perhaps two old sayings would have some relevance: “when the cat’s away, the mice will play” and “if it ain’t broke, don’t fix it”.

Henry Littler
Wigan


Rectify this ridiculous position!

From Mr J. C. Porteous, MRPharmS

I have read the recent correspondence in The Pharmaceutical Journal and the clarification in the Law and Ethics Bulletin (PJ, 28 August, p298) with both dismay and incredulity. It appears that the highly trained counter staff and qualified dispensers who are available in community pharmacies are not allowed to sell GSL products in the absence of a pharmacist, no matter how temporary.

This does not mean GSL medicines, but products. Our intelligent staff are not to be trusted with the sale of a tube of E45 cream.

I understand that the relevant legislation dates from 1968. How is it possible that the Royal Pharmaceutical Society has done nothing to rectify this ridiculous position? The Society decided that community pharmacy’s counter assistants must undertake a prescribed training course then left them with less ability to sell GSL products than any other retail outlet.

What is the Society going to do about it? How do we get the act amended? Which among our august representative bodies will champion our cause?

Community pharmacies could register part of their premises only (this is what the supermarkets do). I think, however, that this should be a temporary measure. This law is not working as intended and must be changed.

J. C. Porteous
Studley, Warwickshire


Legal position should be changed

From Ms A. M. Baker, MRPharmS

When Lynsey Balmer replied to Paresh Shah’s query about general sale list medicines and their availability from different types of premises (PJ, 11 September, p345), she simply restated the legal position.

I think many of us are aware of the legal position and are not seeking clarification of it, but seeking to understand the reasoning behind it.

It appears to me, and I think to your other correspondents (Leo David, Deborah Kong and Peter Gamblin), to be a strange legal position.

I would like to ask the Royal Pharmaceutical Society to lobby the Government in order that this legal position be changed.

If such lobbying is already taking place,then perhaps someone from the Society would be able to confirm that our concerns are being addressed. If not, perhaps someone would kindly raise the issue at a meeting of the Society's Council.

Alison Baker
Dumfries


Crass legislation

From Mrs J. M. Wood, MRPharmS

In response to the letters on the subject of sale of general sale list medicines, the Royal Pharmaceutical Society yet again responds merely by quoting the legislation as it currently stands but fails to express a view. Is it not it time the Society started working for the members and lobbying for such crass legislation to be changed? Too often the Society hides behind poor legislation to justify inaction. How can we expect the public to respect us when they apparently get better service from a supermarket check-out assistant than from a registered pharmacy?

Julia Wood
Leeds


Non-registered areas

From Mr M. G. J. Cooper, MRPharmS

Lynsey Balmer states that GSL medicines can be sold from non-pharmacy premises (PJ, 11 September, p345). Therefore, if supermarkets can sell GSL medicines from non-registered areas of their premises, why cannot every pharmacy do the same and designate part of its premises non-registered with the Royal Pharmaceutical Society?

M. G. J. Cooper
Bishop’s Stortford, Hertfordshire


A few simple rules

From Mr S. Vohra, MRPharmS

Since I wrote my first letter on the sale of GSL medicines (PJ, 28 August, p286), there has been much debate and consternation expressed but no solutions seem to have been proposed on how pharmacists should deal with the issue. I would like to recommend a course of action. We should all follow a few simple rules:

1. Always recommend a P medicine and never a GSL one. This will ensure we are not indirectly aiding GSL sales in non-pharmacy outlets — if they can pick the product you recommended off the shelf elsewhere why bother coming to you again?

2. Stay clear of those branded P medicines that have prominent, well-advertised GSL alternatives. This should prevent customers from selecting the same brand GSL medicines in non-pharmacy outlets.

3. Follow the example of Lloydspharmacy and bring your P medicines out onto the shop floor displayed behind transparent plastic shields. This allows customers greater access and choice in selecting P medicines.

4. Cut down on your GSL range and stock brands that the supermarkets do not keep.

Pharmacists should remember that P medicines are always advertised as being “stronger” than GSL medicines. The above steps, therefore, should ensure that this message is emphasised and the importance of pharmacists and pharmacies in medicine sales recognised.

Samir Vohra
Preston, Lancashire


Absurd anomaly

From Mr D. J. Coleman, MRPharmS

It was with dismay that I read the Law and Ethics Bulletin (PJ, 28 August, p298) and the official response to letters in the PJ (11 September, p345) on the subject of general sale list sales.

When a clearly absurd situation is revealed (that is that the regulations appear to prohibit a trained medicines counter assistant from selling GSL medicines in the absence of a pharmacist yet allows staff at the grocery store checkout to sell them) then what is needed, if confidence in the professional role of the Royal Pharmaceutical Society is to be maintained, is to know what steps are being taken to rectify this absurd anomaly in the regulations. To point out further anomalies, ie, that in a supermarket situation, even with an in-store pharmacy only the pharmacy area is registered thus allowing untrained staff to sell GSL medicines just makes the situation more ridiculous.

This reduces the credibility of the profession and undermines the respect and confidence of the public in GSL medicines. A meeting with pharmacy superintendents of the major multiples, the National Pharmaceutical Association and patient representatives might be a start. There is an issue of public safety. There is also a need for pharmacists to be able to take some sort of a break (if only for 10 minutes) in a 10-hour day without closing the pharmacy down.

David Coleman
North Walsham, Norfolk

Send your letter to The Editor

Previous Topic (The register)
Next Topic (The Society)

Back to Top


©The Pharmaceutical Journal